9-132927168-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000368.5(TSC1):​c.210+33G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00901 in 1,602,738 control chromosomes in the GnomAD database, including 118 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0074 ( 12 hom., cov: 32)
Exomes 𝑓: 0.0092 ( 106 hom. )

Consequence

TSC1
NM_000368.5 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: -1.30

Publications

2 publications found
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • lung lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-132927168-C-T is Benign according to our data. Variant chr9-132927168-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 48892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00742 (1130/152318) while in subpopulation SAS AF = 0.0199 (96/4832). AF 95% confidence interval is 0.0167. There are 12 homozygotes in GnomAd4. There are 522 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1130 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC1NM_000368.5 linkc.210+33G>A intron_variant Intron 4 of 22 ENST00000298552.9 NP_000359.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC1ENST00000298552.9 linkc.210+33G>A intron_variant Intron 4 of 22 1 NM_000368.5 ENSP00000298552.3
TSC1ENST00000490179.4 linkc.210+33G>A intron_variant Intron 5 of 23 3 ENSP00000495533.2

Frequencies

GnomAD3 genomes
AF:
0.00742
AC:
1130
AN:
152200
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00118
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00799
Gnomad ASJ
AF:
0.0323
Gnomad EAS
AF:
0.00519
Gnomad SAS
AF:
0.0199
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0101
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.00945
AC:
2317
AN:
245130
AF XY:
0.0103
show subpopulations
Gnomad AFR exome
AF:
0.00127
Gnomad AMR exome
AF:
0.00796
Gnomad ASJ exome
AF:
0.0239
Gnomad EAS exome
AF:
0.00489
Gnomad FIN exome
AF:
0.00165
Gnomad NFE exome
AF:
0.00920
Gnomad OTH exome
AF:
0.0113
GnomAD4 exome
AF:
0.00918
AC:
13315
AN:
1450420
Hom.:
106
Cov.:
28
AF XY:
0.00960
AC XY:
6929
AN XY:
721426
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33280
American (AMR)
AF:
0.00824
AC:
365
AN:
44304
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
614
AN:
25948
East Asian (EAS)
AF:
0.00162
AC:
64
AN:
39614
South Asian (SAS)
AF:
0.0201
AC:
1708
AN:
84784
European-Finnish (FIN)
AF:
0.00254
AC:
135
AN:
53164
Middle Eastern (MID)
AF:
0.00817
AC:
47
AN:
5750
European-Non Finnish (NFE)
AF:
0.00881
AC:
9725
AN:
1103572
Other (OTH)
AF:
0.0103
AC:
621
AN:
60004
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
717
1435
2152
2870
3587
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00742
AC:
1130
AN:
152318
Hom.:
12
Cov.:
32
AF XY:
0.00701
AC XY:
522
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.00118
AC:
49
AN:
41572
American (AMR)
AF:
0.00798
AC:
122
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0323
AC:
112
AN:
3472
East Asian (EAS)
AF:
0.00521
AC:
27
AN:
5186
South Asian (SAS)
AF:
0.0199
AC:
96
AN:
4832
European-Finnish (FIN)
AF:
0.000848
AC:
9
AN:
10608
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0101
AC:
686
AN:
68032
Other (OTH)
AF:
0.00993
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
53
106
158
211
264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00968
Hom.:
4
Bravo
AF:
0.00767
Asia WGS
AF:
0.0120
AC:
42
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 18, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Tuberous sclerosis 1 Benign:2
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tuberous sclerosis syndrome Other:1
-
Tuberous sclerosis database (TSC1)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.048
DANN
Benign
0.49
PhyloP100
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118203350; hg19: chr9-135802555; COSMIC: COSV104404434; API